US Competitiveness in Synthetic Biology

Area of Science:

• Synthetic biology engineering
• Biotechnology innovation

Background:

• Synthetic biology (SynBio) is a rapidly advancing field with significant economic implications.
• The US currently leads in SynBio R&D, but global investments pose a challenge to this position.
• SynBio applications span economic growth, national defense, and global governance.

Purpose of the Study:

• To outline strategies for the US to maintain its leadership in synthetic biology.
• To address challenges including global competition and public perception of genetically modified organisms (GMOs).
• To ensure a robust regulatory framework for SynBio products and international cooperation.

Main Methods:

• Analysis of the current synthetic biology landscape and R&D investments.
• Review of potential economic and national security applications of SynBio.
• Examination of regulatory approaches and international agreements impacting SynBio.

Main Results:

• Sustained US leadership requires proactive government strategies beyond general S&T investment.
• Addressing anti-GMO sentiments and legislation is crucial for SynBio development.
• Maintaining a product-based regulatory approach while updating frameworks is essential.

Conclusions:

• The US must act to remain competitive in synthetic biology R&D and application.
• Policy adjustments are needed to counter anti-GMO sentiments and ensure regulatory clarity.
• International engagement is vital for governing SynBio and realizing its benefits.